DRMA

Dermata Therapeutics, Inc.

0.46 USD
-0.00 (-0.76%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dermata Therapeutics, Inc. stock is down -7.04% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 March’s closed higher than February.

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.